← Eichor
Condition: Irritability Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Irritability

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05803980Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
NA · 1 location(s) · Oregon Health and Science University · NCT06133231Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers
EARLY_Phase 1 · 2 location(s) · National Institute of Mental Health (NIMH) · NCT06484088Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07635394Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
NA · 2 location(s) · Walter Reed National Military Medical Center · NCT05414708Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Phase 2/Phase 3 · 1 location(s) · Md. Hazrat Ali · NCT07114055Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Phase N/A · 1 location(s) · Brown University · NCT05754190Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction
NA · 1 location(s) · Karolinska Institutet · NCT07319078Efficacy of Probiotics in Patients With IBD
NA · 1 location(s) · The First Affiliated Hospital of Xinxiang Medical College · NCT05652621Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)
NA · 1 location(s) · Magnus Simrén · NCT06413004Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
NA · 1 location(s) · Nova Scotia Health Authority · NCT05721742Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics
Phase 1/Phase 2 · 1 location(s) · Universidad de Colima · NCT06268964A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
NA · 3 location(s) · PGP Health · NCT07540312Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07517029Methacholine Challenge Test in School Children With/Without Asthma RISKA
Phase N/A · 1 location(s) · Helsinki University Central Hospital · NCT07031102A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Phase 2 · 70 location(s) · Eli Lilly and Company · NCT07545772Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Phase 1 · 1 location(s) · Xiyuan Hospital of China Academy of Chinese Medical Sciences · NCT06737666B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
EARLY_Phase 1 · 2 location(s) · Jinling Hospital, China · NCT06612411Validation of TRansanal Irrigation Adherence scaLe (TRIAL)
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06805903The Role That Food and Bacteria Play in Generating Abdominal Pain
NA · 1 location(s) · David Reed · NCT07688044Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100
Phase 1 · 1 location(s) · Valenta Pharm JSC · NCT07421011Fluoxetine on Emotional Experience (FLEX) Study
NA · 1 location(s) · University of Oxford · NCT07424781Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
NA · 1 location(s) · University of California, Los Angeles · NCT06668922AP Metabolism Transcriptomics
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT06814314Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NA · 1 location(s) · University of Michigan · NCT03687814Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD
NA · 2 location(s) · Attikon Hospital · NCT06749613Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
Phase 4 · 1 location(s) · Milton S. Hershey Medical Center · NCT06871488Probiotics and Biomarkers in Irritable Bowel Syndrome
NA · 1 location(s) · Sahlgrenska University Hospital · NCT07584278A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms
NA · 2 location(s) · Biokuris s.a. · NCT06104631
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.